Photo of Joel S. Pachter, Ph.D.

Joel S. Pachter, Ph.D.

Professor, Department of Immunology
Academic Office Location:
Cell Biology
UConn Health
263 Farmington Avenue
Farmington, CT 06030-6125
Phone: 860-679-3698
Fax: 860-679-3693

Cell Biology Graduate Program

The major focus in this laboratory is to elucidate the mechanisms by which leukocytes and pathogens invade the central nervous system (CNS). Movement of both soluble and cellular elements into the CNS is regulated by microvessel endothelial cells comprising the blood-brain barrier (BBB). It is thus believed that alterations in the BBB contribute to the pathogenesis of various neuroinflammatory, neuroinfectious and neurodegenerative diseases such as multiple sclerosis, AIDS dementia complex and Alzheimer disease. To evaluate the role played by the BBB in these disorders, we are employing an in vitro culture model of the human BBB recently developed in this laboratory.

Studies in progress in this laboratory include the following:

1.) Analysis of cell-targeted chemokine knockouts (developed in this laboratory) to determine the role of site-specific release of chemokines in neuroinflammatory disease.
2.)Assessing how normal aging affects cerebral angiogenesis in different brain regions, and the role of different exercise regimens in modifying age-related affects on cerebrovascular properties.
3.)Using laser capture microdissection (LCM) coupled with gene array and proteomic platforms to characterize the extent and nature of heterogeneity along the microvascular tree of the central nervous system.
4.)Using LCM to probe changes in the blood-brain barrier that accompany cerebral ischemia.

Accepting Lab Rotation Students: Summer 2022, Fall 2022, and Spring 2023

Lab Rotation Projects
My laboratory is currently performing gene profiling of the cells comprising the neurovascular unit in the central nervous system (endothelial cells, astrocytes, and perivascular microglia/pericytes. Specifically, laser capture microdissection of these cells in situ is being coupled to quantitative, real-time PCR and DNA microarray platforms. The objective is to determine molecular finger prints of the neurovascular unit throughout the CNS microvascular tree. As different vascular beds exhibit unique phenotypes, such an approach will be critical in identifying why particular CNS regions are prone to diseases with vascular involvement, such as MS, stroke and Alzheimer's disease.

Journal Articles




Short Surveys